Download PDF
Thromb Haemost 2000; 83(05): 786
DOI: 10.1055/s-0037-1613910
Letters to the Editor
Schattauer GmbH

Type ICD36 Deficiency in Humans Is not Associated with Insulin Resistance Syndrome

Hidekatsu Yanai
1   From the Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan
,
Hitoshi Chiba
1   From the Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan
,
Mie Morimoto
2   Hokkaido University College of Medical Technology, Sapporo, Japan
,
G. A. Jamieson
3   American Red Cross, Rockville, Md., USA
,
Kazuhiko Matsuno
2   Hokkaido University College of Medical Technology, Sapporo, Japan
› Author Affiliations
Further Information

Publication History

Received 10 November 1999

Accepted 19 November 1999

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Altman JA, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet 1999; 21: 76-83.
    CrossrefPubMedGoogle Scholar
  • 2 Yamamoto N, Akamatsu H, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392-7.
    PubMedGoogle Scholar
  • 3 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
    CrossrefPubMedGoogle Scholar
  • 4 Watanabe K, Ohta Y, Toba K, Ogawa Y, Hanawa H, Hirokawa Y, Kodama M, Tanabe N, Hirono S, Ohkura Y, Nakamura Y, Kato K, Alzawa Y, Fuse I, Miyajima S, Kusano Y, Nagamoto T, Hasegawa G, Naito M. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann Nucl Med 1998; 12: 261-6.
    CrossrefPubMedGoogle Scholar